Cargando…

Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer

As many as 30% to 40% of locally advanced rectal cancer (LARC) patients experience metastatic progression of the disease. Recognizing the potential of the genetic cargo in tumor-derived exosomes, we hypothesized that plasma exosomal microRNA (miRNA) may reflect biological aggressiveness in LARC and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meltzer, Sebastian, Bjørnetrø, Tonje, Lyckander, Lars Gustav, Flatmark, Kjersti, Dueland, Svein, Samiappan, Rampradeep, Johansen, Christin, Kalanxhi, Erta, Ree, Anne Hansen, Redalen, Kathrine Røe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542769/ https://www.ncbi.nlm.nih.gov/pubmed/31146167 http://dx.doi.org/10.1016/j.tranon.2019.04.014

Ejemplares similares

Corrigendum to “Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer” [Transl Oncol 12 (8) (2019) 1038–1044]
por: Meltzer, Sebastian, et al.
Publicado: (2019)

Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer
por: Meltzer, Sebastian, et al.
Publicado: (2016)

Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks
por: Ree, Anne Hansen, et al.
Publicado: (2014)

Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening
por: Kalanxhi, Erta, et al.
Publicado: (2016)

An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer
por: Bjørnetrø, Tonje, et al.
Publicado: (2019)

Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition
por: Porzycki, Paweł, et al.
Publicado: (2018)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)

Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
por: Zedan, A. H., et al.
Publicado: (2020)

Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
por: Kalanxhi, Erta, et al.
Publicado: (2018)

Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy
por: Kalanxhi, Erta, et al.
Publicado: (2017)

Biomarkers of Histone Deacetylase Inhibitor Activity in a Phase 1 Combined-Modality Study with Radiotherapy
por: Ree, Anne Hansen, et al.
Publicado: (2014)

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
por: Hektoen, Helga Helseth, et al.
Publicado: (2015)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

Expression and prognostic significance of miR-375 and miR-221 in liver cancer
por: Xie, Dafei, et al.
Publicado: (2017)

Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer
por: Lynch, Seodhna M., et al.
Publicado: (2016)

Significance of miR-141 and miR-340 in cervical squamous cell carcinoma
por: Li, Wenting, et al.
Publicado: (2021)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke
por: Salman, Aya Tarek, et al.
Publicado: (2023)

Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
por: Antolín, Silvia, et al.
Publicado: (2015)

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
por: Bains, Simer J., et al.
Publicado: (2019)

Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer
por: Mahdavinezhad, Ali, et al.
Publicado: (2015)

miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
por: Campayo, Marc, et al.
Publicado: (2018)

miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies
por: Solis-Vivanco, Adriana, et al.
Publicado: (2022)

Evaluation of serum miR‐216a and miR‐375 as biomarkers in dogs with acute pancreatitis
por: Lee, Dohee, et al.
Publicado: (2022)

Potential Diagnostic and Prognostic Utility of miR-141, miR-181b1, and miR-23b in Breast Cancer
por: Taha, Mohamed, et al.
Publicado: (2020)

NF‐κB inhibition reverses acidic bile‐induced miR‐21, miR‐155, miR‐192, miR‐34a, miR‐375 and miR‐451a deregulations in human hypopharyngeal cells
por: Doukas, Sotirios G., et al.
Publicado: (2018)

Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed samples from oral potentially malignant disorders
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma
por: Chen, Xuanyu, et al.
Publicado: (2018)

Expression and diagnostic value of miR-34c and miR-141 in serum of patients with colon cancer
por: Wu, Huijing, et al.
Publicado: (2020)

miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
por: Choi, Nahyun, et al.
Publicado: (2015)

The PBX1/miR-141-miR-200a/EGR2/SOCS3 Axis; Integrative Analysis of Interaction Networks to Discover the Possible Mechanism of MiR-141 and MiR-200a-Mediated Th17 Cell Differentiation
por: Bahmani, Leila, et al.
Publicado: (2023)

miR-375 and miR-30d in the Effect of Chromium-Containing Chinese Medicine Moderating Glucose Metabolism
por: Zhang, Qian, et al.
Publicado: (2014)

Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China
por: He, Yutong, et al.
Publicado: (2016)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

MiR-93/miR-375: Diagnostic Potential, Aggressiveness Correlation and Common Target Genes in Prostate Cancer
por: Ciszkowicz, Ewa, et al.
Publicado: (2020)

The Role of miR-375-3p and miR-200b-3p in Gastrointestinal Stromal Tumors
por: Gyvyte, Ugne, et al.
Publicado: (2020)

Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer
por: Li, Ming, et al.
Publicado: (2020)

Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer
por: Pietrus, Miłosz, et al.
Publicado: (2021)

High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD
por: van Nijnatten, Jos, et al.
Publicado: (2022)

MiR-375 and miR-21 as Potential Biomarkers of Prostate Cancer: Comparison of Matching Samples of Plasma and Exosomes
por: Joković, Suzana Matijašević, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_el2ugftp8lkgdov2juiolu29t2